Khader Yousef, Khatatbeh Moawiah, El-Salem Khalid, Amarin Zouhair, Bateiha Anwar
Department of Community Medicine, Public Health and Family Medicine, Jordan University of Science & Technology, Irbid, Jordan.
J Cardiometab Syndr. 2008 Fall;3(4):224-8. doi: 10.1111/j.1559-4572.2008.00020.x.
This study was conducted to determine the prevalence of the metabolic syndrome (MeS) and its associated factors among patients undergoing cardiac catheterization in north Jordan. A cross-sectional study was conducted among patients who underwent cardiac catheterization at King Abdullah University Hospital in north Jordan. Data from 360 patients were collected through personal interview, medical records, and anthropometric measurements. MeS was defined using National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) and International Diabetes Federation (IDF) criteria. The prevalence of MeS among patients undergoing cardiac catheterization in north Jordan was 64.7% according to NCEP ATP III criteria and 76.7% according to IDF criteria. About 96.7% of the participants had at least 1 metabolic abnormality. Sex, body mass index, and family history of cardiovascular disease were the only variables significantly associated with MeS. The prevalence of MeS among patients undergoing cardiac catheterization in north Jordan is considerably high, especially among women.
本研究旨在确定约旦北部接受心脏导管插入术患者中代谢综合征（MeS）的患病率及其相关因素。对约旦北部阿卜杜拉国王大学医院接受心脏导管插入术的患者进行了一项横断面研究。通过个人访谈、病历和人体测量收集了360名患者的数据。采用美国国家胆固醇教育计划成人治疗小组第三次报告（NCEP ATP III）和国际糖尿病联盟（IDF）标准定义MeS。根据NCEP ATP III标准，约旦北部接受心脏导管插入术患者中MeS的患病率为64.7%，根据IDF标准为76.7%。约96.7%的参与者至少有1种代谢异常。性别、体重指数和心血管疾病家族史是与MeS显著相关的仅有的变量。约旦北部接受心脏导管插入术患者中MeS的患病率相当高，尤其是在女性中。
